Annuncio pubblicitario
Italia markets close in 5 hours 39 minutes
  • FTSE MIB

    34.178,92
    -117,39 (-0,34%)
     
  • Dow Jones

    38.386,09
    +146,43 (+0,38%)
     
  • Nasdaq

    15.983,08
    +55,18 (+0,35%)
     
  • Nikkei 225

    38.405,66
    +470,90 (+1,24%)
     
  • Petrolio

    82,79
    +0,16 (+0,19%)
     
  • Bitcoin EUR

    58.726,11
    -631,68 (-1,06%)
     
  • CMC Crypto 200

    1.285,99
    -53,08 (-3,95%)
     
  • Oro

    2.327,60
    -30,10 (-1,28%)
     
  • EUR/USD

    1,0735
    +0,0010 (+0,10%)
     
  • S&P 500

    5.116,17
    +16,21 (+0,32%)
     
  • HANG SENG

    17.763,03
    +16,12 (+0,09%)
     
  • Euro Stoxx 50

    4.953,17
    -27,92 (-0,56%)
     
  • EUR/GBP

    0,8550
    +0,0016 (+0,18%)
     
  • EUR/CHF

    0,9777
    +0,0018 (+0,18%)
     
  • EUR/CAD

    1,4684
    +0,0037 (+0,25%)
     

Vertex Shares Have Been Heavily Accumulated All Year

Vertex Pharmaceuticals Attracts Big Money Inflows

Want an edge in trading? Follow the Big Money.

What’s Big Money? Said simply, it’s when a stock rises due to institutional demand. Top stocks tend to attract savvy investors.

You see, fund managers are always looking to bet on the next outperforming stocks…the best in class. They spend countless hours sizing up companies, reading reports, speaking to analysts…you name it. When they find a company firing on all cylinders, they pounce in a big way.

The 1-Year action tells the story. Each green bar signals unusual buying volumes in VRTX shares, pushing the stock higher:

Source: www.mapsignals.com
Source: www.mapsignals.com

Few stocks have charts this strong. Recent green bars suggest healthy demand. But, what about the fundamental story?

Vertex Pharmaceuticals Fundamental Analysis

Next, I want to make sure the fundamental story is healthy too. As you can see, VRTX has had positive sales growth and earnings growth the last 3 years:

ANNUNCIO PUBBLICITARIO
  • 3-year sales growth rate (+29.3%)

  • 3-year EPS growth rate (+52.5%)

The forward estimates have EPS growth at +9.5%, giving an attractive forward outlook.

Source: FactSet

Marrying great fundamentals with our proprietary Big Money software has found some big winning stocks over the long-term.

Check this out. Vertex Pharmaceuticals has been a top-rated stock at MAPsignals. That means the stock has had buy pressure and growing fundamentals. We have a ranking process that showcases stocks like this on a weekly basis.

It’s made the rare Top 20 report numerous times. The blue bars below show when VRTX was a top pick:

Source: www.mapsignals.com
Source: www.mapsignals.com

Tracking unusual volumes reveals the power of the MAPsignals process.

Vertex Pharmaceuticals Price Prediction

The VRTX rally has been in place all year. Big Money buying in the shares is signaling to take notice. Given the historical gains in share price and strong fundamentals, this stock could be worth a spot in a diversified portfolio.

Disclosure: the author holds no positions in VRTX at the time of publication.

If you want to take your investing to the next level, learn more about the MAPsignals process here.

This article was originally posted on FX Empire

More From FXEMPIRE: